Select Publications
Journal articles
2017, 'Hepatitis A to E: what's new?', Internal Medicine Journal, 47, pp. 380 - 389, http://dx.doi.org/10.1111/imj.13386
,2017, 'Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study', Antiviral Therapy, 22, pp. 699 - 710, http://dx.doi.org/10.3851/IMP3168
,2016, 'A survey of Sydney general practitioners' management of patients with chronic hepatitis B', The Medical journal of Australia, 204, http://dx.doi.org/10.5694/mja15.00524
,2016, 'Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: Position paper produced by Australian, UK and New Zealand key opinion leaders', Gut, 65, pp. 340 - 350, http://dx.doi.org/10.1136/gutjnl-2015-310317
,2015, 'Corrigendum to "efficacy and safety of tenofovir disoproxil fumarate (TDF) in pregnancy to prevent perinatal transmission of hepatitis B virus" (J Hepatol (2014) 61:502-507)', Journal of Hepatology, 63, pp. 1054, http://dx.doi.org/10.1016/j.jhep.2015.07.017
,2015, 'Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis', Journal of Gastroenterology and Hepatology (Australia), 30, pp. 453 - 462, http://dx.doi.org/10.1111/jgh.12865
,2014, 'A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection', AIDS Research and Therapy, 11, http://dx.doi.org/10.1186/1742-6405-11-35
,2014, 'Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: Lack of potency and selection of resistance mutations', Journal of Viral Hepatitis, 21, pp. 809 - 817, http://dx.doi.org/10.1111/jvh.12212
,2014, 'Anti-viral therapy for prevention of perinatal HBV transmission: Extending therapy beyond birth does not protect against post-partum flare', Alimentary Pharmacology and Therapeutics, 39, pp. 1225 - 1234, http://dx.doi.org/10.1111/apt.12726
,2014, 'Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 179 - 184, http://dx.doi.org/10.1111/jgh.12424
,2014, 'Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus', Journal of Hepatology, 61, pp. 502 - 507, http://dx.doi.org/10.1016/j.jhep.2014.04.038
,2014, 'Editorial: anti-viral therapy for prevention of perinatal HBV transmission - extending therapy beyond birth and the risk of post-partum flare; authors' reply', Alimentary Pharmacology & Therapeutics, 40, pp. 116 - 116, http://dx.doi.org/10.1111/apt.12806
,2012, 'Lamivudine in pregnancy: impact on hepatitis flares and HBeAg seroconversion post partum', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27, pp. 181 - 181, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600367&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'The hepatitis B bear: novel patient orientated information enhances patient understanding of the phases of hepatitis B', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27, pp. 166 - 166, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600340&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Preventing Perinatal Transmission of HBV: An Australian Perspective', Current Hepatitis Reports, 11, pp. 206 - 212, http://dx.doi.org/10.1007/s11901-012-0144-4
,2011, 'Nucleot(s)ide analogues to prevent perinatal transmission of HBV: Lamivudine is effective but Tenofovir may be better', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 26, pp. 100 - 100, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295157300261&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'ANTIVIRAL-THERAPY IN PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: SEVERE POST PARTUM HEPATIC FLARES ARE COMMON AND USUALLY SELF LIMITING', JOURNAL OF HEPATOLOGY, 54, pp. S294 - S295, http://dx.doi.org/10.1016/S0168-8278(11)60735-6
,2010, 'Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: Effects on health services utilisation', BMC Health Services Research, 10, http://dx.doi.org/10.1186/1472-6963-10-215
,2010, 'Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia', Journal of Hepatology, 52, pp. 508 - 513, http://dx.doi.org/10.1016/j.jhep.2010.01.007
,2010, 'Liver transient elastography (Fibroscan®): A place in the management algorithms of chronic viral hepatitis', Antiviral Therapy, 15, pp. 1 - 11, http://dx.doi.org/10.3851/IMP1474
,2010, 'Adverse Impact of Hepatitis C Virus Infection on Renal Replacement Therapy and Renal Transplant Patients in Australia and New Zealand', Transplantation, 90, pp. 1165 - 1171, http://dx.doi.org/10.1097/TP.0b013e3181f92548
,2009, 'Serum HBeAg and HBsAg titres: changing levels during the natural history of chronic hepatitis B', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A299 - A299, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'In reply', Medical Journal of Australia, 191, pp. 357, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02829.x
,2009, 'Perinatal transmission of hepatitis B virus: an Australian experience REPLY', MEDICAL JOURNAL OF AUSTRALIA, 191, pp. 357 - 357, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02829.x
,2009, 'Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer', Journal of Hepatology, 50, pp. 990 - 998, http://dx.doi.org/10.1016/j.jhep.2008.12.022
,2009, 'Perinatal transmission of hepatitis B virus: an Australian experience', Medical Journal of Australia, 190, pp. 489 - 492
,2009, 'Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users', Health Promotion Journal of Australia, 20, pp. 234 - 240
,2008, 'Hepatitis C has a significant impact after renal transplantation: analysis of the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23, pp. A260 - A260, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most', Internal Medicine Journal, 37, pp. 516 - 522
,2002, 'Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate', Journal of Hepatology, 37, pp. 214 - 221, http://dx.doi.org/10.1016/S0168-8278(02)00103-4
,2000, 'Molecular pathogenesis of liver disease: An approach to hepatic inflammation, cirrhosis and liver transplant tolerance', Immunological Reviews, 174, pp. 172 - 191, http://dx.doi.org/10.1034/j.1600-0528.2002.017420.x
,2000, 'Oncostatin M: A cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells', Journal of Hepatology, 32, pp. 218 - 226, http://dx.doi.org/10.1016/S0168-8278(00)80066-5
,1999, 'Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted β propeller domain', European Journal of Biochemistry, 266, pp. 798 - 810, http://dx.doi.org/10.1046/j.1432-1327.1999.00902.x
,1999, 'Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis', Hepatology, 29, pp. 1768 - 1778, http://dx.doi.org/10.1002/hep.510290631
,1999, 'Posterior pharyngolaryngitis. Double-blind randomised placebo-controlled trial of proton pump inhibitor therapy', Australian Journal of Otolaryngology, 3, pp. 243 - 246
,1999, 'Posterior pharyngolaryngitis: Double-blind placebo controlled trial of proton pump inhibitor therapy', Australian Journal of Otolaryngology, pp. 243 - 246
,1997, 'Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: Referral patterns and transplant outcomes', Journal of Gastroenterology and Hepatology (Australia), 12, pp. 453 - 459, http://dx.doi.org/10.1111/j.1440-1746.1997.tb00466.x
,1997, 'Molecular analyses of human and rat dipeptidyl peptidase IV', Advances in Experimental Medicine and Biology, 421, pp. 161 - 169, http://dx.doi.org/10.1007/978-1-4757-9613-1_21
,1996, 'Case Report: Delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis', Journal of Gastroenterology and Hepatology (Australia), 11, pp. 734 - 737, http://dx.doi.org/10.1111/j.1440-1746.1996.tb00323.x
,1993, 'Viral markers in the treatment of hepatitis B and C', Gut, 34
,Conference Papers
2019, 'Evaluating outpatient elective paracentesis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 74 - 74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Stereotactic body radiation therapy for portal vein tumor thrombus is a safe and valuable therapy for the palliation of advanced hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 103 - 103, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Hepatitis B virus (HBV) DNA integration is not driven by viral proteins', in Zeitschrift für Gastroenterologie, Georg Thieme Verlag KG, presented at 35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber, 22 February 2019 - 23 February 2019, http://dx.doi.org/10.1055/s-0038-1677293
,2017, 'An Observational, Prospective Epidemiological Registry in Australia of HCV Liver Disease (OPERA-C)', in HEPATOLOGY, WILEY, DC, Washington, pp. 528A - 528A, presented at 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, DC, Washington, 20 October 2017 - 24 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412089801129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Can Quantitative HBsAg Threshold Predict High Viral Load and Risk of Mother to Child Transmission? Like Life, You Get What You Pay For', in HEPATOLOGY, WILEY, DC, Washington, pp. 1009A - 1010A, presented at 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, DC, Washington, 20 October 2017 - 24 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412089802260&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Project ECHO in Australia: A novel tele-mentoring service to aid Hepatitis C treatment in difficult to access populations', in HEPATOLOGY, WILEY, DC, Washington, pp. 317A - 318A, presented at 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, DC, Washington, 20 October 2017 - 24 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412089800581&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Can quantitative HBsAg threshold predict high viral load and risk of mother-to-child transmission? Like life, you get what you pay for', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 82 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Effect of direct-acting antivirals on hepatocellular carcinoma incidence in hepatitis C virus-related cirrhosis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 75 - 75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Project ECHO: A novel tele-mentoring service to aid hepatitis C treatment in difficult-to-access populations', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 67 - 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'EFFECT OF TENOFOVIR ON KEY HEPATITIS B VIRUS MARKERS IN PREGNANT WOMEN DURING THE THIRD TRIMESTER AND POSTPARTUM', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, AUSTRIA, Vienna, pp. S565 - S565, presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, AUSTRIA, Vienna, 22 April 2015 - 26 April 2015, http://dx.doi.org/10.1016/S0168-8278(15)30857-6
,